![Mark Hopman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Hopman
Corporate Officer/Principal chez
BETA BIONICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Mark Hopman currently works at Beta Bionics, Inc., as Chief Commercial Officer from 2024.
Mr. Hopman also formerly worked at DexCom, Inc., as Senior Director-Trade from 2017 to 2021 and Pear Therapeutics (US), Inc., as Vice President-Market Access from 2021 to 2023.
Mr. Hopman received his Masters Business Admin degree from Williams College of Business and undergraduate degree from The Ohio State University College of Pharmacy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BETA BIONICS, INC. 0,29% | 04/06/2026 | 130 612 ( 0,29% ) | 2 M $ | 31/05/2026 |
BETA BIONICS, INC. -.--% | 29/01/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Mark Hopman
| Sociétés | Poste | Début |
|---|---|---|
| BETA BIONICS, INC. | Corporate Officer/Principal | 01/03/2023 |
Anciens postes connus de Mark Hopman
| Sociétés | Poste | Fin |
|---|---|---|
Pear Therapeutics (US), Inc.
 Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications | Corporate Officer/Principal | 01/03/2023 |
| DEXCOM, INC. | Corporate Officer/Principal | 01/06/2021 |
Formation de Mark Hopman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
DexCom, Inc.
 DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
Williams College of Business
 Williams College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pear Therapeutics (US), Inc.
Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications | Technology Services |
The Ohio State University College of Pharmacy
 The Ohio State University College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
